March 5, 2020 / 2:09 PM / in 23 days

BRIEF-Outlook Therapeutics Announces LYTENAVA, Anticipated Brand Name For ONS-5010, If Approved

March 5 (Reuters) - Outlook Therapeutics Inc:

* OUTLOOK THERAPEUTICS ANNOUNCES LYTENAVA™ (BEVACIZUMAB-VIKG), ANTICIPATED BRAND NAME FOR ONS-5010, IF APPROVED

* OUTLOOK THERAPEUTICS INC - HAS RECEIVED U.S. FOOD AND DRUG ADMINISTRATION TENTATIVE APPROVAL OF TRADENAME FOR ONS-5010 AS LYTENAVA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below